Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients?

Journal of Cachexia, Sarcopenia and Muscle - Tập 5 Số 3 - Trang 177-180 - 2014
Connie M. Rhee1,2, Kamyar Kalantar-Zadeh1,2,3
1Harold Simmons Center for Chronic Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine Medicine Center, 101 The City Drive South, City Tower, 92868-3217 Orange, CA
2Los Angeles Biomedical Research Institute, Harbor-UCLA, Torrance, CA
3Veterans Affairs Long Beach Health Care System, Long Beach, CA

Tóm tắt

Muscle wasting is a common complication afflicting maintenance hemodialysis (HD) patients, and it is associated with decreased muscle function, exercise performance, physical function, and quality of life. Meanwhile, numerous epidemiologic studies have consistently shown that greater muscle mass (ascertained by body anthropometry surrogates, body composition tests such as dual x‐ray absorptiometry, and/or serum creatinine in patients with little to no residual kidney function) is associated with increased survival in this population. The pathophysiology of muscle wasting in HD patients is complex and may be caused by poor dietary intake, catabolic effects of dialysis therapy, hormonal alterations (e.g., decreased levels or resistance to anabolic hormones, increased levels of catabolic hormones), inflammation, metabolic acidosis, and concurrent comorbidities. Muscle disuse resulting from low physical activity is an important yet under‐appreciated risk factor for muscle wasting. Intra‐dialytic resistance exercise training has been suggested as a potential strategy to correct and/or prevent this complication in HD patients, but prior studies examining this exercise modality as an anabolic intervention have shown mixed results. In a recently published 12‐week randomized controlled trial of a novel intra‐dialytic progressive resistance exercise training (PRET) program vs. control therapy conducted in HD and non‐HD patients, PRET resulted in increased muscle volume and strength in both groups. At this time, further study is needed to determine if anabolic improvements imparted by resistance exercise translates into improved physical function and quality of life, decreased hospitalization and mortality risk, and greater cost‐effectiveness in HD patients.

Từ khóa


Tài liệu tham khảo

10.1097/MNH.0b013e328331489d

10.1038/sj.ki.5002585

10.1007/s13539-013-0111-0

10.1053/j.jrn.2010.10.012

10.1046/j.1523-1755.2003.00704.x

10.4065/mcp.2010.0336

10.1093/aje/kwr384

10.1111/j.1600-6143.2011.03468.x

10.2215/CJN.02080310

10.1053/j.ajkd.2010.10.003

10.1016/j.mayocp.2013.01.025

10.1093/ndt/gft213

10.1007/s13539-012-0079-1

10.2215/CJN.09131010

Isoyama N Qureshi AR Avesani CM Lindholm B Barany P Heimburger O et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clinical Journal of the American Society of Nephrology: CJASN. 2014. Epub 2014/07/31.

10.2215/CJN.06920712

Rhee CM Brent GA Kovesdy CP Soldin OP Nguyen D Budoff MJ et al. Thyroid functional disease: an under‐recognized cardiovascular risk factor in kidney disease patients. Nephrology dialysis transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2014. Epub 2014/02/28.

10.2215/CJN.06590712

Kirkman DL Mullins P Junglee NA Kumwenda M Jibani MM Macdonald JH. Anabolic exercise in haemodialysis patients: a randomised controlled pilot study. J Cachexia Sarcopenia Muscle. 2014. Epub 2014/04/09.

10.1038/ki.2010.312

10.1093/ndt/gfr692

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2005; 45(4 Suppl 3):S1–153.

Physical Activity Guidelines Advisory Committee: Physical Activity Guidelines Advisory Committee Report 2008 Washington DC U.S. Department of Health and Human Services 2008.

Caspersen CJ, 1985, Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research, Public Health Rep, 100, 126

10.1053/ajkd.2003.50001

10.1681/ASN.2007010009

10.1002/art.24891

10.1053/j.ajkd.2011.10.008

10.1681/ASN.2006010034

10.1681/ASN.2006070794

10.1053/j.ajkd.2007.07.005

10.1681/ASN.2006121329

10.1053/j.jrn.2010.03.004

10.1053/ajkd.2002.34520

Thông tin
Thông tin xuất bản

Journal of Cachexia, Sarcopenia and Muscle

Tập 5 Số 3

177-180

Thông tin tác giả